Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Lancet. Diabetes & Endocrinology|October 25, 2016
Leveraging the immune system to treat advanced thyroid cancersJena D French, Keith Bible, Christine Spitzweg, et al.
Antioxidants & Redox Signaling|November 13, 2008
The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductaseJennifer D Tibodeau, Linda M Benson, Crescent R Isham, et al.
Frontiers in Immunology|January 18, 2024
Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancerAnupam Kotwal, Michael P Gustafson, Svetlana Bornschlegl, et al.
Clinical Nuclear Medicine|December 22, 2020
123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid CancerJolanta M Durski, Carrie B Hruska, Trond V Bogsrud, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2015
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupKeith C Bible, Gilbert J Cote, Michael J Demeure, et al.
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
Medicine|September 10, 2024
Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy studyLivia Maria Frota Lima, Trond Velde Bogsrud, Hossein Gharib, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|July 21, 2011
Functional vagal paraganglioma: a case report illustrating diagnosis and managementHeidi Hornbeek, N Gopalakrishna Iyer, Diane L Carlson, et al.
Pageof 10